Anushree Chatterjee, Ph.D

Founder President of ARC Laboratories

Dr. Anushree Chatterjee has 15+ years of experience in synthetic and systems biology. She is the inventor of a number of technologies for countering emerging, evolving and drug-resistant pathogens including FAST platform, Quantum dot antibiotics, and CHAOS therapy. She received her Bachelors and Masters of Technology in Chemical Engineering from Indian Institute of Technology Delhi in 2006. She earned her Ph.D. in Chemical engineering at the University of Minnesota on understanding molecular mechanisms of antibiotic resistance transfer in clinical superbugs in 2011. She was a postdoctoral research fellow at the Theoretical Biology and Biophysics group at Los Alamos National Laboratory studying gene regulation of hepatitis C virus till 2012. In 2013, Anushree joined the faculty at University of Colorado Boulder. She has published 45+ papers in high-impact peer-reviewed journals, given 55 invited talks, and 70+ contributed talks. Anushree has received numerous awards including the DARPA Young Faculty Award, ACS Infectious Diseases Young Investigator Award, New Inventor of the Year award, Provost’s Faculty Achievement award, and the prestigious William M. Keck Foundation grant award. Anushree’s research has been featured by academic and federal institutions such as the Material Research Society, Faculty of 1000, and the National Science Foundation, as well as popular national and international media outlets including BBC, CGTN America, and Voice of America. She has also founded/co-founded two Biotech startup companies, and serves as a board member for COVID- International Research Team. She also serves as an Associate Professor of Chemical and Biological Engineering at the University of Colorado Boulder.